Heba Nowyhed, PhD

Senior Associate, Vida Ventures

Dr. Nowyhed has over 13 years of experience in Immunobiology, and 3+ years of combined experience working with the business development group at LJI and with the OCR office at Yale.

She received her Ph.D. at Yale University where she focused on identifying key drivers of autoimmunity across various disease settings. She completed her Postdoctoral Fellowship in the Inflammation Department at the La Jolla Institute for Allergy and Immunology in late 2015. There she studied T cell biology and investigated the intrinsic mechanisms that drive the development of T cell lineages in models of acute infection, as well as atherosclerosis, IBD, and other chronic inflammatory settings.

Early 2016, Dr. Nowyhed joined the Research group at Kite Pharma as a Scientist where she played a key role in generating the pre-clinical data packages for 2 IND filings. She went on to lead a pipeline program as a Senior Scientist that resulted in 3 more successful IND filings. As an Associate Director, she successfully established key cross functional collaborations between Research and Product Sciences, developed and led an Assay and Automation group, as well as led a team developing next-generation products for Kite’s solid tumor programs.